About Cellebrite DI
Ticker
info
CLBT
Trading on
info
NASDAQ
ISIN
info
IL0011794802
Industry
info
Software - Infrastructure
Sector
info
Technology
CEO
info
Thomas E. Hogan
Headquarters
info
94 Shlomo Shmelzer Road, Petah Tikva, undefined, Israel, 4970602
Employees
info
1,285
Website
info
cellebrite.com
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Metrics
BasicAdvanced
Market cap
info
$3.7B
P/E ratio
info
47.87
EPS
info
$0.31
Dividend Yield
info
0.00%
Beta
info
1.33
Forward P/E ratio
info
35.71
EBIDTA
info
$78.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$3.7B
Average daily volume
info
1.7M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
47.87
Forward P/E
info
35.71
PEG ratio
info
-
Trailing P/E
info
47.87
Price to sales
info
7.78
Price to book
info
7.35
Earnings
EPS
info
$0.31
EPS estimate (current quarter)
info
$0.14
EPS estimate (next quarter)
info
$0.11
EBITDA
info
$78.3M
Revenues (TTM)
info
$476M
Revenues per share (TTM)
info
$1.97
Technicals
Beta
info
1.33
52-week High
info
$20.86
52-week Low
info
$11.76
50-day moving average
info
$14.92
200-day moving average
info
$16.33
Short ratio
info
1.99
Short %
info
3.44%
Management effectiveness
ROE (TTM)
info
19.10%
ROA (TTM)
info
5.10%
Profit margin
info
16.47%
Gross profit margin
info
$401M
Operating margin
info
16.15%
Growth
Quarterly earnings growth (YoY)
info
1.80%
Quarterly revenue growth (YoY)
info
18.10%
Share stats
Outstanding Shares
info
249M
Float
info
123M
Insiders %
info
43.14%
Institutions %
info
53.85%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 8 analysts.

Average price target

info
$21.67
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.10
$0.09
11.11%
Q1 • 25Beat
$0.12
$0.11
9.09%
Q2 • 25Beat
$0.14
$0.13
7.69%
Q3 • 25Beat
$0.08
$0.09
-11.11%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$126M
$20.2M
16.02%
Q3 • 25
$129M
$21.3M
16.50%
Q4 • 25
2.22%
5.31%
3.03%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$834M
$387M
46.34%
Q3 • 25
$939M
$455M
48.41%
Q4 • 25
12.53%
17.56%
4.47%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$33.3M
$63.8M
$5.3M
$30M
Q3 • 25
$82.2M
$-94.7M
$6.9M
$78.3M
Q4 • 25
147.13%
-248.46%
31.48%
161.34%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Cellebrite DI share?
Collapse

Cellebrite DI shares are currently traded for undefined per share.

How many shares does Cellebrite DI have?
Collapse

Cellebrite DI currently has 249M shares.

Does Cellebrite DI pay dividends?
Collapse

No, Cellebrite DI doesn't pay dividends.

What is Cellebrite DI 52 week high?
Collapse

Cellebrite DI 52 week high is $20.86.

What is Cellebrite DI 52 week low?
Collapse

Cellebrite DI 52 week low is $11.76.

What is the 200-day moving average of Cellebrite DI?
Collapse

Cellebrite DI 200-day moving average is $16.33.

Who is Cellebrite DI CEO?
Collapse

The CEO of Cellebrite DI is Thomas E. Hogan.

How many employees Cellebrite DI has?
Collapse

Cellebrite DI has 1,285 employees.

What is the market cap of Cellebrite DI?
Collapse

The market cap of Cellebrite DI is $3.7B.

What is the P/E of Cellebrite DI?
Collapse

The current P/E of Cellebrite DI is 47.87.

What is the EPS of Cellebrite DI?
Collapse

The EPS of Cellebrite DI is $0.31.

What is the PEG Ratio of Cellebrite DI?
Collapse

The PEG Ratio of Cellebrite DI is null.

What do analysts say about Cellebrite DI?
Collapse

According to the analysts Cellebrite DI is considered a buy.